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Background
The popular recreational abuse drug 3,4-methylenedi-
oxymethamphetamine (MDMA, 'Ecstasy') produces acute
and long-lasting deficits in several markers of the seroton-
ergic (5-HT) system. BDNF (brain derived neurotrophic
factor) is a prominent trophic factor of serotonergic fibers.
The aim of this study was to characterize the damage of
serotonergic fibers in the frontoparietal cortex and hip-
pocampus in parallel with the expression of BDNF.
Methods
Male Dark Agouti rats (7 weeks old) were treated with a
single (15 mg/kg, i.p.) dose of MDMA. Density of tryp-
tophan hydroxylase (TpH) immunoreactive (ir) fibers was
quantified 3 days and 3 weeks after treatment. BDNF pro-
tein and mRNA levels were measured by ELISA and quan-
titative PCR method 24 hours and 3 weeks after treatment.
Results
Findings from TpH-ir fiber density revealed significant
(30-50%) decrease, compared to baseline, both 3 days
and 3 weeks after treatment in both hippocampus and the
frontoparietal cortex. Results from ELISA showed that
BDNF level in the frontoparietal cortex dropped signifi-
cantly (30%) 24 hours and 3 weeks after treatment. This
decrease in BDNF concentration was also confirmed with
the quantitative PCR method. In contrast, no such a
reduction was found in the hippocampus.
Conclusion
Our findings show that administration of a single dose of
MDMA, a neurotoxic agent, leads to a significant drop in
the TpH-ir axon density with a parallel decrease in BDNF
levels 3 days and 3 weeks after treatment in the frontopa-
rietal cortex. In contrast, in the hippocampus, the reduc-
tion of TpH-ir axon density is not accompanied by the
decrease of BDNF level. These results highlight regional
differences in the expression of BDNF, the main neuro-
trophic factor of serotonergic fibers, in the terminal sero-
tonergic areas after a neurotoxic dose of MDMA.
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